Evidence map›Paper›PMID 18719393›Full record

ReviewCell cycle (Georgetown, Tex.)2008

Musashi1: a stem cell marker no longer in search of a function.

Robert I Glazer, Xiao-Yang Wang, Hongyan Yuan, Yuzhi Yin

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell cycle (Georgetown, Tex.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Expression of Musashi-1 Increases in Bone Healing.International journal of molecular sciences · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Robert I GlazerDepartment of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA. glazerr@georgetown.edu
Xiao-Yang Wang
Hongyan Yuan
Yuzhi Yin
Georgetown University · US

Funding

PDK1 and PPARdelta Signaling in Mammary TumorigenesisR01CA111482 · NCI · GEORGETOWN UNIVERSITY · PI GLAZER, ROBERT I. · 2006 to 2010
$1.4M
NEW APPROACHES TO ANALYSIS OF BIOPOLYMERSR01CA043309 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI VARSHAVSKY, ALEXANDER J · 1986 to 1990
–
NCI NIH HHS N01 CN043309NCI NIH HHS R01 CA111482NCI NIH HHS R01CA11482
6 · The paper itself

Abstract

One of the earliest genes identified with stem and early progenitor cells is the RNA-binding protein, Musashi1 (Msi1). Through gene profiling of mammary epithelial cells transduced with Msi1, a unique autocrine signaling pathway was identified that activates both the Wnt and Notch pathways. This process was associated with increased secretion of the growth factor, PLF1 and inhibition of the secreted Wnt pathway inhibitor, DKK3. Identification of PLF1 as an effector of these pathways in the absence of the DKK3 tumor suppressor provides a new avenue for investigating differences between normal and malignant tissues, and potentially targeting tumor stem cells.

Indexed as

AnimalsBiomarkersFemaleGlycoproteinsHumansMammary Glands, HumanNerve Tissue ProteinsSignal TransductionStem CellsBiomarkersGlycoproteinsNerve Tissue Proteins

Identifiers

PMID18719393
PMCPMC3676649
OpenAlexW2012608371

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.